
Canada pauses some counter tariffs against US
This came as Prime Minister Mark Carney and US Vice President JD Vance discussed trade in Rome after they attended the inauguration mass at the Vatican for Pope Leo XIV.
According to a readout from Carney's office, they spoke about "immediate trade pressures and the need to build a new economic and security relationship",
In a brief statement, Vance called it "a casual meeting" about their two nations' shared interests and goals, "including fair trade policies".
Carney, who won Canada's Apr 28 election on a pledge to stand up to US President Donald Trump, had slapped counter tariffs on billions of dollars of imports from the United States in response to US tariffs on Canadian goods.
During the election campaign, automakers were offered a reprieve, provided they maintained production and investment in Canada.
This was outlined on May 7 in the Canada Gazette, the government's official newspaper, along with a pause on tariffs on products used in food and beverage processing and packaging, health, manufacturing, national security and public safety.
The moves went mostly unnoticed until Oxford Economics said in a report this week that the exemptions covered so many categories of products that the tariffs rate against the United States was effectively dropped to "nearly zero".
Opposition leader Pierre Poilievre pounced on the claim, cited in the media, to accuse Carney of having "quietly dropped retaliatory tariffs to 'nearly zero' without telling anyone".
Champagne called those assertions falsehoods.
"To retaliate against US tariffs, Canada launched its largest-ever response – including CA$60B of tariffs on end-use goods. 70 per cent of those tariffs are still in place," he said on X.
Canada's counter tariffs, his office told AFP, were "calibrated to respond to the US while limiting economic harm to Canada".
Tariff relief was provided for six months to give some Canadian companies "more time to adjust their supply chains and become less dependent on US suppliers", Champagne spokesperson Audrey Milette said.
Canada continues to charge tariffs on roughly CA$43 billion (US$31 billion) of US goods, she added.
The nation of 41 million people sends three-quarters of its exports to the United States, and the latest jobs report shows tariffs imposed by Trump are already damaging the Canadian economy.
The US president has slapped general tariffs of 25 per cent on Canada as well as sector-specific levies on autos, steel and aluminium, but he has suspended some of them pending negotiations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNA
6 hours ago
- CNA
EU could target US$84 billions of US goods if tariff talks fail
BRUSSELS: The European Commission on Monday (Jul 14) said it was putting forward a new list of US goods worth €72 billion (US$84 billion) that could be targeted by EU levies if tariff talks with Washington fail. The bloc's trade chief, Commissioner Maros Sefcovic, announced the proposal, "accounting for some €72 billion worth of US imports", at a meeting with EU ministers in Brussels. The move came after US President Donald Trump threw months of painstaking negotiations with the EU into disarray by threatening to impose tariffs of 30 per cent on the bloc's goods if there is no deal by Aug 1. EU trade ministers agreed they were still keen to secure an agreement with Washington before that deadline to head off the damaging duties. But at the same time Brussels is moving to ready potential retaliation if Trump presses ahead with the sweeping tariffs. "There was a total unified position among the ministers that we should be ready to respond if needed," said Denmark's foreign minister, Lars Lokke Rasmussen, whose country holds the EU's rotating presidency. The EU has already prepared a separate list of US imports worth €21 billion that it is ready to target over earlier tariffs from Trump on steel and aluminium.


CNA
7 hours ago
- CNA
EU says could target US$84 billions of US goods if tariff talks fail
BRUSSELS: The European Commission on Monday (Jul 14) said it was putting forward a new list of US goods worth €72 billion (US$84 billion) that could be targeted by EU levies if tariff talks with Washington fail. The bloc's trade chief, Commissioner Maros Sefcovic, announced the proposal, "accounting for some €72 billion worth of US imports", at a meeting with EU ministers in Brussels. The move came after US President Donald Trump threw months of painstaking negotiations with the EU into disarray by threatening to impose tariffs of 30 per cent on the bloc's goods if there is no deal by Aug 1. EU trade ministers agreed they were still keen to secure an agreement with Washington before that deadline to head off the damaging duties. But at the same time Brussels is moving to ready potential retaliation if Trump presses ahead with the sweeping tariffs. "There was a total unified position among the ministers that we should be ready to respond if needed," said Denmark's foreign minister, Lars Lokke Rasmussen, whose country holds the EU's rotating presidency. The EU has already prepared a separate list of US imports worth €21 billion that it is ready to target over earlier tariffs from Trump on steel and aluminium.


CNA
7 hours ago
- CNA
Zimmer to acquire Monogram Technologies for $177 million, boosting robotics portfolio
Zimmer Biomet it will acquire robotics firm Monogram Technologies for about $177 million, adding Monogram's semi- and fully autonomous surgical products to its expanding robotics portfolio, the companies said on Monday Shares of Monogram more than doubled to $6.70 in premarket trading. WHY IT'S IMPORTANT Medical device makers, including larger peers Medtronic and Johnson & Johnson are seeking to strengthen their robotic surgery offerings. The global market for robotic surgery devices is expected to be worth nearly $16 billion by the end of this decade, according to data analytics firm GlobalData. The deal will allow Warsaw, Indiana-based Zimmer to broaden its robotics platform and gain access to Monogram's semi-autonomous knee replacement technology, which was approved by the U.S. Food and Drug Administration in March 2025. Zimmer expects to integrate Monogram's technology and launch fully autonomous surgical robots and additional applications beyond prosthetic knee replacement by 2027. BY THE NUMBERS Monogram stockholders will receive $4.04 per share in cash upfront, which represents a premium of 22.8 per cent to its last close. The terms also include up to $12.37 per share in contingent value rights, dependent on certain milestones being met by 2030. Zimmer Biomet plans to fund the deal with a combination of cash and available debt financing. WHAT'S NEXT The deal is expected to close later this year. Zimmer expects the deal to be neutral to adjusted earnings per share until 2027, and accretive to earnings from 2028 onward.